Back to Search
Start Over
Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2019 Nov; Vol. 60 (11), pp. 2817-2820. Date of Electronic Publication: 2019 May 06. - Publication Year :
- 2019
- Subjects :
- Aged
Antimetabolites, Antineoplastic economics
Antimetabolites, Antineoplastic therapeutic use
Azacitidine therapeutic use
Combined Modality Therapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation economics
Humans
Leukemia, Myeloid, Acute mortality
Male
Practice Patterns, Physicians' statistics & numerical data
Prognosis
Retrospective Studies
Survival Rate
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Azacitidine economics
Health Care Costs statistics & numerical data
Health Expenditures statistics & numerical data
Induction Chemotherapy economics
Leukemia, Myeloid, Acute economics
Leukemia, Myeloid, Acute therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 60
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31056994
- Full Text :
- https://doi.org/10.1080/10428194.2019.1605512